Remove Definition Remove Disease Remove Nurses
article thumbnail

The Definition of “Fully Vaccinated” Needs to Change

Eye on FDA

We have the emergence of monoclonal antibodies and protease inhibitors being utilized or being considered as treatments for various stages of disease. Today CDC provided important insight into the ability of the new variant to make headway with a highly vulnerable population when it released data on infections in the nursing home environment.

Vaccine 72
article thumbnail

Mother of 4-Year-Old Living With KAND, One of the Rarest Disorders in the World, Advocates to Find a Cure

KIF1A

By ANDREA SWINDALL, First Published: 8:34 AM PDT, April 6, 2024 KIF1A Associated Neurological Disorder is a rare severe neurodegenerative disease caused by mutations in the KIF1A gene, Amanda Burrett says. KAND is a rare and severe neurodevelopmental and neurodegenerative disease, according to KIF1A.org. Where’s the best therapy?

Doctors 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New England Journal of Medicine Publishes Positive Initial Regeneron Antibody Cocktail Results in Non-hospitalized Patients with COVID-19

The Pharma Data

These follow-on data provided the first definitive prospective evidence demonstrating anti-viral activity for a treatment regimen now available for COVID-19, and also further documented the ability of this treatment to decrease the need for further medical attention,” said George D. Have chronic kidney disease. Have diabetes.

article thumbnail

Covid-19: Health workers 'sick' with fear at thought of second wave

The Pharma Data

‘A scary time’ Clementine Stott, an organ donation specialist nurse at Worcester Royal Hospital, was redeployed to the intensive care unit during the first wave which, for her, meant separating from her 10-year-old son for seven weeks. We spoke to medical staff to see how they were approaching the possible fresh wave of cases.

Nurses 52
article thumbnail

Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses

The Pharma Data

Definition of High-Risk Patients. Have chronic kidney disease. Have immunosuppressive disease. cardiovascular disease, OR. chronic obstructive pulmonary disease/other chronic respiratory disease. sickle cell disease, OR. congenital or acquired heart disease, OR. sickle cell disease, OR.

article thumbnail

Regeneron’s Casirivimab and Imdevimab Antibody Cocktail for COVID-19 is First Combination Therapy to Receive FDA Emergency Use Authorization

The Pharma Data

The FDA grants Emergency Use Authorization to medicines that may help diagnose, treat or prevent a life-threatening disease when adequate and approved alternatives are not available. Definition of High-Risk Patients. Have chronic kidney disease. Have immunosuppressive disease. Are ?

article thumbnail

FDA Clears Second COVID Vaccine for Emergency Use

The Pharma Data

National Institute of Allergy and Infectious Diseases. As the first doses of Pfizer’s coronavirus vaccine made their way to the arms of health care workers around the United States, a new survey from the Kaiser Family Foundation showed that 71% of Americans say they will “definitely or probably” get a COVID-19 vaccine.

Vaccine 52